BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 18985542)

  • 1. Altered small-bowel mucosal vascular network in untreated coeliac disease.
    Myrsky E; Syrjänen M; Korponay-Szabo IR; Mäki M; Kaukinen K; Lindfors K
    Scand J Gastroenterol; 2009; 44(2):162-7. PubMed ID: 18985542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
    Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
    Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
    Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
    Lindfors K; Kaukinen K; Mäki M
    Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase in celiac disease: role of autoantibodies.
    Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
    Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.
    Bazzigaluppi E; Roggero P; Parma B; Brambillasca MF; Meroni F; Mora S; Bosi E; Barera G
    Dig Liver Dis; 2006 Feb; 38(2):98-102. PubMed ID: 16386476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease.
    Salmi TT; Collin P; Järvinen O; Haimila K; Partanen J; Laurila K; Korponay-Szabo IR; Huhtala H; Reunala T; Mäki M; Kaukinen K
    Aliment Pharmacol Ther; 2006 Aug; 24(3):541-52. PubMed ID: 16886921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
    Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR
    Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice.
    Kalliokoski S; Piqueras VO; Frías R; Sulic AM; Määttä JA; Kähkönen N; Viiri K; Huhtala H; Pasternack A; Laurila K; Sblattero D; Korponay-Szabó IR; Mäki M; Caja S; Kaukinen K; Lindfors K
    Amino Acids; 2017 Mar; 49(3):529-540. PubMed ID: 27503559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
    Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
    Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
    Kaukinen K; Sulkanen S; Mäki M; Collin P
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.